Trial HIV vaccine triggers elusive and essential antibodies, pointing the way toward a successful vaccine
An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical ...
https://medicalxpress.com/news/2024-05-trial-hiv-vaccine-triggers-elusive.html